SFV HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Amgen Inc. of Thousand Oaks announced Monday the expansion of its commercial collaboration with Swiss pharma company Novartis International for migraine medication erenumab.
Simulations Plus Inc. has signed a distribution deal in India with pharmaceutical testing equipment manufacturer Electrolab India Pvt. Ltd.
C.R. “Bob” Hudson, chief financial officer and senior vice president at Henry Mayo Newhall Hospital, will retire in July, the Valencia health care facility has announced.
Drug Tests in Bulk of West Hills, an online provider of drug tests for businesses and government agencies, plans to move its headquarters to a newly acquired building in Northridge, according to Hudson Commercial Partners Inc. in Studio City.
Second Sight Medical Products Inc. has successfully implanted its Argus II Retinal Prosthesis System in its first patient in Asia via an exclusive distribution deal with Taiwanese pharmaceutical company Orient Europharma Co. Ltd. as well as a donation from the Hong-Lu Foundation in Taiwan.
In a tale of two studies, health researchers report that Amgen Inc.’s cholesterol medication Repatha reduces the risk of heart disease, while another study finds that insurers balk at paying the steep price for the first-in-its-class drug.
Against the green hills of Thousand Oaks’ preserved open space, executives from Atara Biotherapeutics Inc. gathered Wednesday morning with developers, bankers, politicians and commercial real estate brokers to celebrate the groundbreaking of the drug maker’s new facility.
As many as 500 Amgen Inc. employees in Thousand Oaks have been notified that they will either be relocated, reassigned or laid off, according to a report from Thousand Oaks Acorn.
Sienna Biopharmaceuticals Inc., a Westlake-Village biotech working on novel laser hair removal and skin therapies, announced Friday the appointment of Chief Financial Officer Richard Peterson, effective immediately.
Second Sight Medical Products Inc. announced Monday that warrants issued in connection with a recent rights offering have been approved for listing on Nasdaq and are scheduled to begin trading on March 29.
Amgen Inc.’s biosimilar to the best-selling drug of all time has been approved for commercialization by the European Commission, the company announced Thursday.
Amgen Inc. is opening a 136,000-square-foot facility in Tampa, Fla., the Tampa Hillsborough Economic Development Corp. announced Wednesday.
MannKind Corp. (MNKD) on Thursday reported fourth-quarter and full-year financial results, beating analysts’ expectations.
Northeast Valley Health Corp. on Monday announced the appointment of its new chief medical officer, Dr. Christine Park.
Roundup of quarterly reports from Valley companies.